Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study-Reference-Cited by-同舟云学术

Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study

Published:2022-04-22 Issue:14 Volume:128 Page:2736-2745
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sheshadri Ajay¹^ORCID,Goizueta Alberto A.¹,Shannon Vickie R.¹,London David¹,Garcia‐Manero Guillermo²^ORCID,Kantarjian Hagop M.²^ORCID,Ravandi‐Kashani Farhad²,Kadia Tapan M.²^ORCID,Konopleva Marina Y.²,DiNardo Courtney D.²^ORCID,Pierce Sherry²,Zarifa Abdulrazzak³,Albittar Aya A.³,Zhong Linda L.³,Akhmedzhanov Fechukwu O.³,Arain Muhammad H.¹,Alfayez Mansour²^ORCID,Alotaibi Ahmad²,Altan Mehmet⁴,Naing Aung³,Mendoza Tito R.⁵^ORCID,Godoy Myrna C. B.⁶,Shroff Girish⁶,Kim Sang T.⁷,Faiz Saadia A.¹^ORCID,Kontoyiannis Dimitrios P.⁸,Khawaja Fareed⁸,Jennings Kristofer⁹,Daver Naval G.²^ORCID

Affiliation:

1. Department of Pulmonary Medicine The University of Texas MD Anderson Cancer Center Houston Texas

2. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas

3. Department of Investigational Cancer Therapeutics The University of Texas MD Anderson Cancer Center Houston Texas

4. Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

5. Department of Symptom Research The University of Texas MD Anderson Cancer Center Houston Texas

6. Department of Diagnostic Imaging The University of Texas MD Anderson Cancer Center Houston Texas

7. Department of Rheumatology The University of Texas MD Anderson Cancer Center Houston Texas

8. Department of Infectious Diseases The University of Texas MD Anderson Cancer Center Houston Texas

9. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas

Funder

National Institute of Allergy and Infectious Diseases

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34229

Reference36 articles.

1. Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

3. Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes

4. Outcomes of Allogeneic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-analysis

5. Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center;Cancers;2024-01-15

2. Pulmonary Immune-Related Adverse Events of PD-1 Versus PD-L1 Checkpoint Inhibitors: A Retrospective Review of Pharmacovigilance;Journal of Immunotherapy and Precision Oncology;2023-11-01

3. Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer;Clinical Oncology;2023-10

4. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept;Frontiers in Immunology;2023-09-29

5. Common methodological pitfalls in ICI pneumonitis risk prediction studies;Frontiers in Immunology;2023-09-25